The Next Insulin Scandal

A generic cold medicine available in Europe also turns out to have benefits for Parkinson’s. Biden could prevent the usual effort to patent it and jack up the price.

by

Unlike many news organizations, the Prospect has remained staunchly committed to keeping our journalism free and accessible to all. We believe that independent journalism is crucial for a functioning democracy—but quality reporting comes at a cost.

This year, we’re aiming to raise $75,000 to continue delivering the hard-hitting investigative journalism you’ve come to expect from us. Your support helps us maintain our independence and dig deeper into the stories that matter most.

If you value our reporting, please consider making a contribution today. Any amount helps secure our future and ensure we can continue holding power to account.


Will you support independent journalism with a donation to the Prospect?